| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Laboratory of Immunology and Vascular Biology, Department of Pathology, and Digestive Disease Center, Stanford University School of Medicine, Stanford, CA 95305, and Center of Molecular Biology in Medicine, Foothill Research Center, Veterans Administration Medical Center, Palo Alto, CA 94304;
Istituto di Patologia Generale, Universitá degli Studi di Verona, Strada le Grazie, Verona, Italy; and
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892
Migration of lymphocytes from the blood into the brain is a critical event in the pathogenesis of experimental autoimmune encephalomyelitis. Lymphocyte adhesion to brain endothelium is the first step in lymphocyte entry into the central nervous system, leading subsequently to myelin damage and paralysis. In this paper we show that the tyrosine kinase inhibitor, tyrphostin AG490, prevents binding of freshly isolated mouse lymph node cells and of in vivo activated lymphocytes to endothelium of inflamed brain in Stamper-Woodruff adhesion assays. Moreover, AG490 inhibits adhesion of encephalitogenic T cell lines to purified ICAM-1 and VCAM-1, molecules implicated in T cell recruitment into the central nervous system. In contrast, 2-h treatment of T cell lines with high doses of tyrphostin AG490 have no effect on the viability, intracellular calcium elevation induced by Con A or TCR cross-linking, proliferation, or TNF production by Ag-stimulated T cell lines. Systemic administration of AG490 prevents the accumulation of leukocytes in the brain and the development of experimental autoimmune encephalomyelitis induced by proteolipid protein, peptide 139–151-specific T cell lines in SJL/J mice. Blood leukocytes isolated from mice treated with tyrphostin AG490 are less adhesive on purified very late Ag-4 ligands compared with adhesion of leukocytes from control animals. Our results suggest that inhibition of signaling pathways involved in lymphocyte adhesion may represent a novel therapeutic approach for demyelinating diseases.
This article has been cited by other articles:
|
|
 |
|
  K. Angstwurm, U.-K. Hanisch, T. Gassemi, M. B. Bille, M. Prinz, U. Dirnagl, H. Kettenmann, and J. R. Weber Tyrosine Kinase Inhibition Reduces Inflammation in the Acute Stage of Experimental Pneumococcal Meningitis Infect. Immun., June 1, 2004; 72(6): 3294 - 3298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gismondi, J. Jacobelli, R. Strippoli, F. Mainiero, A. Soriani, L. Cifaldi, M. Piccoli, L. Frati, and A. Santoni Proline-Rich Tyrosine Kinase 2 and Rac Activation by Chemokine and Integrin Receptors Controls NK Cell Transendothelial Migration J. Immunol., March 15, 2003; 170(6): 3065 - 3073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Stein, S. F. Soriano, C. M'rini, C. Nombela-Arrieta, G. G. de Buitrago, J. M. Rodriguez-Frade, M. Mellado, J.-P. Girard, and C. Martinez-A. CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway Blood, January 1, 2003; 101(1): 38 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Vicentini, P. Mazzi, E. Caveggion, S. Continolo, L. Fumagalli, J. A. Lapinet-Vera, C. A. Lowell, and G. Berton Fgr Deficiency Results in Defective Eosinophil Recruitment to the Lung During Allergic Airway Inflammation J. Immunol., June 15, 2002; 168(12): 6446 - 6454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Walters, G. Pryce, D. J. R. Hankey, S. M. Sebti, A. D. Hamilton, D. Baker, J. Greenwood, and P. Adamson Inhibition of Rho GTPases with Protein Prenyltransferase Inhibitors Prevents Leukocyte Recruitment to the Central Nervous System and Attenuates Clinical Signs of Disease in an Animal Model of Multiple Sclerosis J. Immunol., April 15, 2002; 168(8): 4087 - 4094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Piccio, B. Rossi, E. Scarpini, C. Laudanna, C. Giagulli, A. C. Issekutz, D. Vestweber, E. C. Butcher, and G. Constantin Molecular Mechanisms Involved in Lymphocyte Recruitment in Inflamed Brain Microvessels: Critical Roles for P-Selectin Glycoprotein Ligand-1 and Heterotrimeric Gi-Linked Receptors J. Immunol., February 15, 2002; 168(4): 1940 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Piccardoni, R. Sideri, S. Manarini, A. Piccoli, N. Martelli, G. de Gaetano, C. Cerletti, and V. Evangelista Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin Blood, July 1, 2001; 98(1): 108 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Behbod, R. A. Erwin-Cohen, M.-E. Wang, B. W. Trawick, X. Qu, R. Verani, B. D. Kahan, S. M. Stepkowski, and R. A. Kirken Concomitant Inhibition of Janus Kinase 3 and Calcineurin-Dependent Signaling Pathways Synergistically Prolongs the Survival of Rat Heart Allografts J. Immunol., March 15, 2001; 166(6): 3724 - 3732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cuzzocrea, M. C. McDonald, E. Mazzon, D. Siriwardena, G. Calabro, D. Britti, G. Mazzullo, A. De Sarro, A. P. Caputi, and C. Thiemermann The Tyrosine Kinase Inhibitor Tyrphostin AG126 Reduces the Development of Acute and Chronic Inflammation Am. J. Pathol., July 1, 2000; 157(1): 145 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Wang, R. A. Kirken, X. Y. Yang, R. A. Erwin, L. DaSilva, C.-R. Yu, and W. L. Farrar Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells Blood, June 15, 2000; 95(12): 3816 - 3822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Bright, C. Du, and S. Sriram Tyrphostin B42 Inhibits IL-12-Induced Tyrosine Phosphorylation and Activation of Janus Kinase-2 and Prevents Experimental Allergic Encephalomyelitis J. Immunol., May 15, 1999; 162(10): 6255 - 6262. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
